The GMP/GDP Questions & Answers Guide – Version 3.0 (September 2026)

A Practical Reference Guide for Pharmaceutical GMP & GDP Professionals

GMP and GDP requirements can be complex—and finding clear answers to specific regulatory questions can often be time-consuming.

To make this process easier, The GMP/GDP Questions & Answers Guide – Version 3.0 (September 2026) brings together a comprehensive collection of regulatory questions and answers covering a wide range of pharmaceutical quality and compliance topics.

This 230-page reference guide provides an extensive collection of Q&As covering requirements and regulatory expectations from major international sources, including EMA/EU, FDA (USA), MHRA (UK), ICH and ECA Academy.

🔍 What can you find inside?

The guide covers important areas such as:

• EU GMP & GDP requirements
• Pharmaceutical Quality Systems
• Quality Risk Management (QRM)
• Health-Based Exposure Limits (HBEL)
• Cross-contamination control
• Cleaning and cleaning validation
• Production and packaging
• Equipment and qualification
• Outsourced activities
• Complaints, quality defects & recalls
• Data Integrity & Data Lifecycle
• Computerised Systems
• Validation
• Active Pharmaceutical Ingredients (APIs)
• Sterile manufacturing
• Investigational Medicinal Products (IMPs)
• Safety features and traceability
• FDA cGMP requirements
• ICH Q7, Q8, Q9 and Q10
• Visual inspection
• Good Distribution Practices (GDP)
• Temperature mapping
• Supplier qualification
• Deviations and complaints
• Bioburden and microbial control
• Risk assessment and much more.

👨‍🔬 Who will find this guide useful?

This resource can be particularly useful for:

QA | QC | Production | Regulatory Affairs | Validation | Engineering | Warehouse & Supply Chain | GDP Professionals | Pharmacists | GMP Auditors | Consultants | Pharmaceutical Students

Whether you are preparing for a GMP inspection, internal audit, regulatory assessment, deviation investigation, CAPA, validation activity, training session or simply looking for clarification on a GMP/GDP requirement, this guide can serve as a useful reference.

📥 Download the Guide

If you work in the pharmaceutical industry and regularly deal with GMP, GDP, Quality Assurance, Regulatory Affairs, Validation or Compliance, this is a resource worth keeping in your professional reference library.

Download the complete GMP/GDP Questions & Answers Guide – Version 3.0 (September 2026) and keep this valuable regulatory reference at your fingertips.

Download Here

#GMP #GDP #PharmaceuticalIndustry #Pharma #Pharmaceuticals #GMPCompliance #GDPCompliance #QualityAssurance #QualityControl #RegulatoryAffairs #PharmaProfessionals #PharmaQuality #GMPTraining #PharmaTraining #GoodManufacturingPractice #GoodDistributionPractice #DataIntegrity #ICH #EMA #FDA #MHRA #ICHQ7 #ICHQ8 #ICHQ9 #ICHQ10 #QualityRiskManagement #QRM #PharmaRegulatory #PharmaceuticalCompliance #GMPAudit #PharmaAudit #Validation #CAPA #PharmaIndustry #Pharmacy #PharmaKnowledge #PharmaEducation

HEPA Filters & HVAC Systems in Pharmaceutical Manufacturing: Why Clean Air Matters

In pharmaceutical manufacturing, maintaining a controlled environment is fundamental to preventing contamination and protecting product quality. Among the most critical systems supporting this environment are HEPA filtration and HVAC systems.

A cleanroom is not considered controlled simply because it looks clean. Its environmental conditions must be designed, qualified, monitored, maintained and periodically verified to ensure that it consistently performs as intended.

🔹 Role of HEPA Filters

HEPA (High-Efficiency Particulate Air) filters are designed to remove very small airborne particles from the air supplied to controlled areas.

Depending on the application and cleanroom classification, HEPA filtration supports:

• Reduction of airborne particulate contamination

• Maintenance of required cleanroom cleanliness levels

• Protection of exposed products and processes

• Control of contamination in critical manufacturing areas

• Support for aseptic and sterile manufacturing operations

However, installing a HEPA filter alone does not guarantee a compliant cleanroom. Filter integrity, installation quality, airflow distribution and system performance are equally important.

🔹 Role of HVAC Systems

The pharmaceutical HVAC system is responsible for controlling and maintaining several critical environmental parameters, including:

🌡️ Temperature

💧 Relative Humidity

💨 Airflow & Air Changes

↔️ Pressure Differentials

🧹 Particulate Levels

🔄 Air Recirculation / Fresh Air

🚪 Pressure Cascade Between Areas

Proper HVAC design helps ensure that air moves in the intended direction and reduces the potential for contamination transfer between different areas.

🔹 Airflow & Pressure Differentials

One of the most important concepts in pharmaceutical HVAC is directional airflow.

Appropriately designed pressure differentials can help prevent the movement of contaminated air from lower-control areas into higher-control areas.

For sterile and high-risk operations, airflow visualization studies, such as smoke studies, can be used to demonstrate that airflow patterns are appropriate and do not adversely affect product protection.

🔹 Qualification & Continuous Control

A pharmaceutical HVAC system should not simply be installed and forgotten.

Depending on the area and applicable GMP requirements, important activities may include:

✅ Design Qualification (DQ)

✅ Installation Qualification (IQ)

✅ Operational Qualification (OQ)

✅ Performance Qualification (PQ)

✅ HEPA filter integrity testing

✅ Airflow velocity / volume measurements

✅ Air changes per hour assessment

✅ Pressure differential monitoring

✅ Temperature & RH monitoring

✅ Airflow visualization studies

✅ Environmental monitoring

✅ Periodic review and requalification

✅ Preventive maintenance and calibration

🔹 What Do Major GMP Frameworks Emphasize?

Requirements and expectations across USFDA, WHO GMP, EU GMP, Revised Schedule M, MHRA and PIC/S consistently place importance on appropriate facility design, environmental control, filtration, airflow, pressure relationships, qualification and contamination-control measures.

For sterile manufacturing, EU GMP Annex 1 places particular emphasis on the Contamination Control Strategy (CCS) and the appropriate design and control of cleanroom facilities and supporting systems.

Similarly, WHO, PIC/S and other regulatory frameworks emphasize that HVAC and air-handling systems should be appropriately designed and controlled according to the risks associated with the manufacturing operation.

🔹 The Bigger Picture

It is important to remember:

HEPA Filter ≠ Cleanroom Compliance

Compliance depends on the complete system:

Facility Design + HVAC + HEPA Filtration + Airflow + Pressure Cascade + Environmental Monitoring + Qualification + Maintenance + Personnel Practices

When these elements work together effectively, they create a robust contamination-control environment.

Clean Air → Controlled Environment → Quality Product → Patient Safety

For professionals working in QA, QC, Production, Engineering and Sterile Manufacturing, a practical understanding of pharmaceutical HVAC and HEPA filtration is therefore essential.

📌 Follow PharmaText for more practical pharmaceutical, GMP, regulatory and quality-related knowledge.

🌐 www.pharmatext.co.in

#PharmaceuticalManufacturing #HEPAFilter #HVAC #Cleanroom #GMP #cGMP #USFDA #WHOGMP #EUGMP #Annex1 #RevisedScheduleM #MHRA #PICS #ContaminationControl #ContaminationControlStrategy #SterileManufacturing #AsepticManufacturing #EnvironmentalMonitoring #PharmaceuticalEngineering #QualityAssurance #PharmaQuality #GMPCompliance #PatientSafety #PharmaText

Handbook of Investigation and Effective CAPA Systems

Worldwide regulatory agencies perform many inspections annually, and all too often investigation and CAPA system violations are at the top of the list of infractions. Life-sciences regulated companies (not only FDA-regulated ones) must ensure their investigation and CAPA systems look beyond the ‘usual suspects' to identify other quality issues in order to minimize risks (including safe ones) and reduce costs.

Enhancements to this third edition include:

A new section linking the investigation and CAPA programs with the overall quality culture of the company

Fully updated, current versions of regulations including U.S. FDA, EU, ISO 9001, and ISO 13485

Updated inspectional observations from the U.S. FDA and U.K. MHRA

A revised investigation and CAPA processes chapter, which has an improved barrier analysis section, including detailed flowcharts describing the barrier analysis process

New charts and information related to the investigation of human errors; the human factor section includes information about training and competence

A new chapter devoted to analytical laboratory investigations, including a section covering the invalidation of testing results

Updated forms and examples of the different elements of the investigation and CAPA plan, including new case studies; a revised diagnostic tool used for investigating human error

Jose(Pepe) Rodrguez-Perez, PhD, is president of Business Excellence Consulting, Inc., (BEC), a Puerto Rico-based, consulting, training, and remediation firm that focuses on the areas of regulatory compliance, FDA-regulatory training, and risk management. He is a biologist with a doctoral degree in biology from the University of Granada (Spain). Over his career, he has served as an educator, a technical services manager, and as a science advisor to the FDA.

Download

Quality Control Training Manual: Comprehensive Training Guide for API, Finished Pharmaceutical and Biotechnologies Laboratories

Written to help companies comply with GMP, GLP, and validation requirements imposed by the FDA and regulatory bodies worldwide, Quality Control Training Manual: Comprehensive Training Guide for API, Finished Pharmaceutical and Biotechnologies Laboratories presents cost-effective training courses that cover how to apply advances in the life sciences to produce commercially viable biotech products and services in terms of quality, safety, and efficacy. This book and its accompanying CD-ROM comprise detailed text, summaries, test papers, and answers to test papers, providing an administrative solution for management.

• Provides the FDA, Health Canada, WHO, and EMEA guidelines directly applicable to pharmaceutical laboratory-related issues

• Offers generic formats and styles that can be customized to any organization and help management build quality into routine operations to comply with regulatory requirements

• Contains ready-to-use training courses that supply a good source of training material for experienced and inexperienced practitioners in the biotechnology/biopharmaceutical industries

• Includes a CD with downloadable training courses that can be adopted and directly customized to a particular organization

• Supplies ready-to-use test papers that allow end users to record all raw data up to the issuance of the attached certificate

The biotechnology/bioscience industries are regulated worldwide to be in compliance with cGMP and GLP principles, with particular focus on safety issues. Each company must create a definite training matrix of its employees. The training procedures in this book enable end users to understand the principles and elements of manufacturing techniques and provide documentation language ranging from the generic to the specific. The training courses on the CD supply valuable tools for developing training matrices to achieve FDA, Health Canada, EMEA, MHRA UK, WHO, and GLP compliance. 

Download

Good Pharmacovigilance Practice Guide

Pharmacovigilance is the science of collecting, monitoring, researching, assessing and evaluating information from healthcare providers and patients on the adverse effects of medications, biological products, herbalism and traditional medicines with a view to identifying new information about hazards associated with medicines and preventing harm to patients. Pharmacovigilance is particularly concerned with adverse drug reactions.The MHRA has identified a need for writing and publishing a guide to "Good Pharmacovigilance Practice". This text complements current legislation and guidance, and provides practical advice about achieving an appropriate system of pharmacovigilance.

Download

Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007: aka the Orange Guide

Familiarly known as the "Orange Guide," this title combines the major pharmaceutical Regulations, Directives and guidance, which wholesalers and the pharmaceutical industry use as their main source when manufacturing and distributing medicinal products in the EU.

Download [UPDATED]

Testing Computers Systems for FDA/MHRA Compliance

There is no substitute for extensive testing when it comes to IT systems. Recognition that problems are easier and cheaper to fix before the system is in use (rather than after), has turned testing into a cost-effective tool. However, when developing computer systems for pharmaceuticals manufacturing, testing to meet regulatory requirements adds an additional layer of complexity. Testing Computers Systems for FDA/MHRA Compliance focuses on software module, software integration, hardware, and system acceptance testing. Reflecting the renewed emphasis of the FDA and other global regulatory agencies towards systematic inspections and risk-based validation with an underlying scientific rationale, this guide focuses on current best practices in computer systems testing in the regulatory environment. David Stokes demonstrates how the principles detailed in the GAMP 4 Guide can be used to define a pragmatic approach to testing. He includes techniques for testing large Internet-based systems for compliance with the stringent requirements of regulations such as 21CFR Part 11, and clarifies the relationship and responsibilities of the system "user" and "supplier". The author also delineates where testing starts in the project lifecycle, who performs what testing, where the lines of responsibility start and end, and the differences in the terminology used in the healthcare and general IT sectors. A checklist of questions to be used when developing System Test Specification(s), and templates for documenting typical system test results, round out the features that make this book a practical guide for all those involved in the development and implementation of IT systems for the pharmaceutical and related healthcare manufacturing industries. Senior managers, team project leaders, project team members, and industry trainees, will all benefit from this clear and practical guide.

Download

Rules and Guidance for Pharmaceutical Manufacturers and Distributors

Rules and Guidance for Pharmaceutical Manufacturers and Distributors

Publisher:Pharmaceutical Press; Rev Ed edition( 27 April 2007) | ISBN-10: 0853697191 | PDF | 9.3 Mb | 430 pages

Since the 2002 edition of 'Rules and Guidance for Pharmaceutical Manufacturers and Distributors', commonly known as the 'Orange Guide', there have been many changes and additions to the detailed European Community guidelines on Good Manufacturing Practice (GMP). In addition, there is a new Directive dealing specifically with GMP and the Community Code relating to medicinal products for human use (Council Directive 2001/83/EC) has itself been the subject of substantial revision, via amending Directive 2004/27/EC, and these changes have been transposed into UK domestic legislation.

From its first publication in 1971 the 'Orange Guide', has been an essential reference for all involved in the manufacture and distribution of medicines in Europe.

The 'Orange Guide' collates in one convenient and authoritative source European and UK guidance documents and information on legislation relating to the manufacture and distribution of medicines for human use. Compliance with Good Manufacturing Practice and Good Distribution Practice requirements is essential in the production and distribution of medicines for human use to safeguard public health and to comply with legislation.

It is of particular relevance to all holders of Manufacturer’s Licences and Wholesale Dealer’s licences and to their Qualified Persons and Responsible Persons, who have a responsibility for ensuring compliance with many of these regulatory requirements.

Download